{"entity":{"type":"insider","cik":"0001391402","url":"/insider/0001391402","json_url":"/insider/0001391402.json","name":"Finegan Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2012-08-03","last":"2020-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Finegan Michael","source":"filing","n_filings":10,"first_seen":"2012-08-03","last_seen":"2020-06-09"}],"transactions":[{"id":2436501,"accession":"0001209191-20-035294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-035294","line_url":"/filing/0001209191-20-035294#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"Orthofix Medical Inc.","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":37.4083,"price_display":"37.41","price_state":"stated","total_value":327322.625,"total_display":"327,322.62","shares_owned_after":47933.0,"shares_owned_after_display":"47,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-09","scope":"insider"},{"id":6078821,"accession":"0001209191-18-038641","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-038641","line_url":"/filing/0001209191-18-038641#line-4","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19275.0,"shares_display":"19,275","price_per_share":58.6341,"price_display":"58.63","price_state":"stated","total_value":1130172.2775,"total_display":"1,130,172.28","shares_owned_after":47569.0,"shares_owned_after_display":"47,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-19","scope":"insider"},{"id":6078819,"accession":"0001209191-18-038641","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-038641","line_url":"/filing/0001209191-18-038641#line-3","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10725.0,"shares_display":"10,725","price_per_share":59.1262,"price_display":"59.13","price_state":"stated","total_value":634128.495,"total_display":"634,128.50","shares_owned_after":36844.0,"shares_owned_after_display":"36,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-18","filed_date":"2018-06-19","scope":"insider"},{"id":3212187,"accession":"0001209191-16-139780","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-139780","line_url":"/filing/0001209191-16-139780#line-4","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":45.16,"price_display":"45.16","price_state":"stated","total_value":1129000.0,"total_display":"1,129,000.00","shares_owned_after":41670.0,"shares_owned_after_display":"41,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-02","scope":"insider"},{"id":2957460,"accession":"0001209191-16-114617","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-114617","line_url":"/filing/0001209191-16-114617#line-5","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28750.0,"shares_display":"28,750","price_per_share":44.0,"price_display":"44.00","price_state":"stated","total_value":1265000.0,"total_display":"1,265,000.00","shares_owned_after":38774.0,"shares_owned_after_display":"38,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-18","scope":"insider"},{"id":2957445,"accession":"0001209191-16-114617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114617","line_url":"/filing/0001209191-16-114617#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52222.0,"shares_display":"52,222","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":2193324.0,"total_display":"2,193,324.00","shares_owned_after":38774.0,"shares_owned_after_display":"38,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-18","scope":"insider"},{"id":8904933,"accession":"0001209191-15-079501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-079501","line_url":"/filing/0001209191-15-079501#line-1","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (Chief Strategy Officer)","officer_title":"Chief Strategy Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14140.0,"shares_display":"14,140","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":593880.0,"total_display":"593,880.00","shares_owned_after":58252.0,"shares_owned_after_display":"58,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-11","filed_date":"2015-11-12","scope":"insider"},{"id":3407186,"accession":"0000884624-12-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884624-12-000029","line_url":"/filing/0000884624-12-000029#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (President, Biologics)","officer_title":"President, Biologics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":41.201,"price_display":"41.20","price_state":"stated","total_value":123603.0,"total_display":"123,603.00","shares_owned_after":23860.0,"shares_owned_after_display":"23,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-16","filed_date":"2012-08-17","scope":"insider"},{"id":2595869,"accession":"0000884624-12-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884624-12-000028","line_url":"/filing/0000884624-12-000028#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (President, Biologics)","officer_title":"President, Biologics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":41.002,"price_display":"41.00","price_state":"stated","total_value":287014.0,"total_display":"287,014.00","shares_owned_after":23860.0,"shares_owned_after_display":"23,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-15","filed_date":"2012-08-16","scope":"insider"},{"id":2065216,"accession":"0000884624-12-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884624-12-000026","line_url":"/filing/0000884624-12-000026#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (President, Biologics)","officer_title":"President, Biologics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.784,"price_display":"41.78","price_state":"stated","total_value":417840.0,"total_display":"417,840.00","shares_owned_after":23860.0,"shares_owned_after_display":"23,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-10","filed_date":"2012-08-13","scope":"insider"},{"id":2065211,"accession":"0000884624-12-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884624-12-000025","line_url":"/filing/0000884624-12-000025#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (President, Biologics)","officer_title":"President, Biologics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11700.0,"shares_display":"11,700","price_per_share":41.836,"price_display":"41.84","price_state":"stated","total_value":489481.2,"total_display":"489,481.20","shares_owned_after":23860.0,"shares_owned_after_display":"23,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-03","filed_date":"2012-08-06","scope":"insider"},{"id":2180440,"accession":"0000884624-12-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000884624-12-000023","line_url":"/filing/0000884624-12-000023#line-2","is_derivative":false,"issuer_cik":"0000884624","issuer_name":"ORTHOFIX INTERNATIONAL N V","issuer_ticker":"OFIX","issuer_name_source":null,"issuer_url":"/issuer/0000884624","owner_cik":"0001391402","owner_name":"Finegan Michael","owner_url":"/insider/0001391402","role":"Officer (President, Biologics)","officer_title":"President, Biologics","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":41.018,"price_display":"41.02","price_state":"stated","total_value":135359.4,"total_display":"135,359.40","shares_owned_after":23860.0,"shares_owned_after_display":"23,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-02","filed_date":"2012-08-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000884624","name":"Orthofix Medical Inc.","url":"/issuer/0000884624","role":"Officer (Chief Strategy Officer)","n_filings":10,"first_seen":"2012-08-03","last_seen":"2020-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001391402","retrieved_at":"2026-08-21T10:48:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}